(Last updated : 2022-05-26 17:06:04)
  武田 志帆
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Internal Medicine, Division of Nephrology
   Position   Assistant Professor
■ Published papers
1. Original article  Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polystic Kidney Disease 2022/05/20
2. Original article  Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease 2022/01/29
3. Original article  Germline Mutations for Kidney Volume in ADPKD 2021/12/13
4. Original article  Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD 2021/07/14
5. Original article  Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease 2021/07
Display all(26)
■ Academic conference presentation
1. Relationship of tolvaptan dose with the rate of decline in kidney function in ADPKD patients.  2019/11/07
2. Elevation of the liver enzyme levels during tolvaptan treatment with autosomal dominant polycystic kidney disease (ADPKD)  2018/02/22